Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11760158rdf:typepubmed:Citationlld:pubmed
pubmed-article:11760158lifeskim:mentionsumls-concept:C0024198lld:lifeskim
pubmed-article:11760158lifeskim:mentionsumls-concept:C0006033lld:lifeskim
pubmed-article:11760158lifeskim:mentionsumls-concept:C2754943lld:lifeskim
pubmed-article:11760158lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:11760158lifeskim:mentionsumls-concept:C1510996lld:lifeskim
pubmed-article:11760158lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:11760158pubmed:issue11lld:pubmed
pubmed-article:11760158pubmed:dateCreated2001-12-10lld:pubmed
pubmed-article:11760158pubmed:abstractTextThe avidity indices of Borrelia burgdorferi-specific IgG antibodies were estimated using ELISA in sera from patients with different stages of Lyme disease. In addition, sera from healthy students with proof of borrelial-specific IgG antibodies from standard serology were tested. Low avidity indices were detected predominantly in sera from patients with early-stage Lyme disease [erythema migrans (EM); n = 25]. High avidity indices were found in healthy students (n = 72) and in most of the patients with neuroborreliosis (NB; n = 44) and chronic late-stage Lyme disease [acrodermatitis chronica atrophicans (ACA); n = 36]. In conclusion, early-stage Lyme disease (EM) could be differentiated from advanced and chronic stages (NB, ACA) and from "seropositive" healthy persons using avidity determination in the majority of patients in this study.lld:pubmed
pubmed-article:11760158pubmed:languageenglld:pubmed
pubmed-article:11760158pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11760158pubmed:citationSubsetIMlld:pubmed
pubmed-article:11760158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11760158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11760158pubmed:statusMEDLINElld:pubmed
pubmed-article:11760158pubmed:issn0036-5548lld:pubmed
pubmed-article:11760158pubmed:authorpubmed-author:KaiserRRlld:pubmed
pubmed-article:11760158pubmed:authorpubmed-author:NeubertUUlld:pubmed
pubmed-article:11760158pubmed:authorpubmed-author:RasiahCClld:pubmed
pubmed-article:11760158pubmed:authorpubmed-author:RauerSSlld:pubmed
pubmed-article:11760158pubmed:authorpubmed-author:BeitlichPPlld:pubmed
pubmed-article:11760158pubmed:issnTypePrintlld:pubmed
pubmed-article:11760158pubmed:volume33lld:pubmed
pubmed-article:11760158pubmed:ownerNLMlld:pubmed
pubmed-article:11760158pubmed:authorsCompleteYlld:pubmed
pubmed-article:11760158pubmed:pagination809-11lld:pubmed
pubmed-article:11760158pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:meshHeadingpubmed-meshheading:11760158...lld:pubmed
pubmed-article:11760158pubmed:year2001lld:pubmed
pubmed-article:11760158pubmed:articleTitleAvidity determination of Borrelia burgdorferi-specific IgG antibodies in Lyme disease.lld:pubmed
pubmed-article:11760158pubmed:affiliationDepartment of Neurology, Albert Ludwig University, Freiburg, Germany. rauer@nz11.ukl.uni-freiburg.delld:pubmed
pubmed-article:11760158pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11760158pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed